
FDA, Brigham and Women’s to test if RWE is ripe now for replacing clinical drug trials
Can real-world evidence substitute for a clinical drug trial that meets the full gold standard on data?
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,000+ biopharma pros reading Endpoints daily — and it's free.